Catastrophic multiple organ ischemia due to an anti‐Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American journal of hematology/oncology

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ajh.21330PMID 19097173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cryoglobulins

  2008cited by this paper
• Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy

  2007cited by this paper
• Cold hemolytic syndrome.

  2006cited by this paper
• Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.

  2006cited by this paper
• Cold agglutinin disease and cryoglobulinemia.

  2005cited by this paper
• Reappraisal of the clinical expression of mixed cryoglobulinemia

  2005cited by this paper
• Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests.

  2005cited by this paper
• Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients.

  2004cited by this paper
• EFFICACY AND SAFETY OF RITUXIMAB IN TYPE II MIXED CRYOGLOBULINEMIA Short title : rituximab therapy in mixed cryoglobulinemia

  2003cited by this paper
• Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

  2003cited by this paper
• Cryoglobulins.

  2002cited by this paper
• The cryoglobulins: an overview

  2001cited by this paper
• Favourable response to therapy with the anti‐CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

  2001cited by this paper
• Severe cold agglutinin disease and cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda cryoagglutinin.

  1999cited by this paper
• Rituxan in the treatment of cold agglutinin disease.

  1998cited by this paper
• Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia.

  1996cited by this paper
• Failure of interferon‐α‐2b therapy in chronic cold agglutinin disease

  1994cited by this paper
• Red cell destruction in cold agglutinin disease.

  1994cited by this paper
• Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins.

  1991cited by this paper
• Alpha-interferon for severe cold agglutinin disease.

  1989cited by this paper
• Cold agglutinin disease and cryoglobulinemia. Report of two cases.

  1985cited by this paper
• Anti‐Pr cold hemagglutination associated with livedo reticularis

  1985cited by this paper
• Cryopathic gangrene with an IgM lambda cryoprecipitating cold agglutinin

  1978cited by this paper
• Biologic and clinical significance of cryoglobulins. A report of 86 cases.

  1974cited by this paper
• Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

  1966cited by this paper

• Extracorporeal Immunopharmacotherapy of Autoimmune Diseases

  2019cites this paper
• Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome.

  2019cites this paper
• Fatal massive hemolysis caused by immunoglobulin M anti‐c antibody in a patient with newly diagnosed B‐cell acute lymphoblastic leukemia: a case report

  2018cites this paper
• Plasmapheresis in Treatment of Myasthenia Gravis

  2018cites this paper
• Using direct antiglobulin test results to reduce unnecessary cold agglutinin testing

  2017cites this paper
• [Plasmapheresis in treatment of myasthenia gravis].

  2015cites this paper
• Eculizumab as a bridge to immunosuppressive therapy in severe cold agglutinin disease of anti-Pr specificity

  2015cites this paper
• Rituximab therapy for primary glomerulonephritis: Report on two cases.

  2015cites this paper
• Pulmonary congestion due to hypothyroidism and nephrotic syndrome induced by cold agglutinins

  2014cites this paper
• Hyperviscosity in plasma cell dyscrasias

  2013cites this paper
• Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.

  2013cites this paper
• Adverse events to monoclonal antibodies used for cancer therapy

  2013cites this paper
• Preliminary analysis of mortality associated with rituximab use in autoimmune diseases

  2013cites this paper
• In Practice Hepatitis C Virus Infection , Mixed Cryoglobulinemia , and Kidney Disease

  2013cites this paper
• The Role of Rituximab in the Therapy of Mixed Cryoglobulinemia

  2012cites this paper
• PIRR Therapy in HCV-Related Mixed Cryoglobulinemia

  2012cites this paper
• Syndrome des anticorps anti-phospholipides apparu à la suite d’un traitement par rituximab

  2012cites this paper
• Antiphospholipid syndrome development after rituximab treatment.

  2012cites this paper
• Idiopathic Cryoglobulinemic Vasculitis

  2012cites this paper
• Drugs that act on the immune system: cytokines and monoclonal antibodies

  2012cites this paper
• Drugs that act on the immune system

  2011cites this paper
• Microvascular Thrombosis: A Serious and Deadly Pathologic Process in Multiple Diseases

  2011cites this paper
• Life-Threatening Cryoglobulinemia

  2011cites this paper
• Chapitre 8 - Acrosyndromes Vasculaires

  2011cites this paper
• Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

  2011influential citation
• Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature

  2011cites this paper
• Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

  2011cites this paper
• Life‐threatening hemolytic anemia due to an autoanti‐Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination

  2010cites this paper
• Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature

  2010cites this paper
• Hydrogen sulfide attenuates intestinal ischemia‐reperfusion injury when delivered in the post‐ischemic period

  2010cites this paper
• [Rheumatoid arthritis and autoimmune hemolysis: B-cell depletion for remission induction in a patient with rheumatoid arthritis and cold agglutinin disease].

  2010cites this paper
• The Significance of Endothelial Heterogeneity in Thrombosis and Hemostasis

  2010cites this paper
• Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry

  2010cites this paper
• The significance of endothelial heterogeneity in thrombosis and hemostasis.

  2010cites this paper
• Rheumatoide Arthritis und Autoimmunhämolyse

  2010cites this paper
• A new mechanism for immune destruction of red blood cells?

  2010cites this paper
• Role of plasma proteins in whole blood viscosity: A brief clinical review

  2010cites this paper